Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 16, 2020

Total Value: $346M (100.0% shares, 0.0% debt)

Holdings (46)

XBI SPDR SER TR 14.5%
Value $50.26M Shares 451,000 Est. Cost Unrealized
TRILLIUM THERAPEUTICS INC 8.0%
Value $27.71M Shares 1,950,000 Est. Cost $7.71 Unrealized
ASND ASCENDIS PHARMA A/S 5.8%
Value $20.06M Shares 130,000 Est. Cost $130.34 Unrealized
MERSANA THERAPEUTICS INC 5.7%
Value $19.55M Shares 1,050,000 Est. Cost $10.98 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 5.5%
Value $18.93M Shares 575,000 Est. Cost $24.73 Unrealized +23.9%
IMVT IMMUNOVANT INC 5.3%
Value $18.48M Shares 525,000 Est. Cost $11.17 Unrealized +169.3%
CONSTELLATION PHARMCETICLS I 4.2%
Value $14.69M Shares 725,000 Est. Cost $42.72 Unrealized
ADVERUM BIOTECHNOLOGIES INC 3.5%
Value $11.96M Shares 1,161,375 Est. Cost $6.88 Unrealized
MIRATI THERAPEUTICS INC 2.9%
Value $9.963M Shares 60,000 Est. Cost $82.63 Unrealized
ALDX ALDEYRA THERAPEUTICS INC 2.7%
Value $9.263M Shares 1,250,000 Est. Cost $4.21 Unrealized +53.3%
RCKT ROCKET PHARMACEUTICALS INC 2.6%
Value $9.144M Shares 400,000 Est. Cost $15.79 Unrealized +56.0%
SRPT SAREPTA THERAPEUTICS INC 2.6%
Value $9.128M Shares 65,000 Est. Cost $151.97 Unrealized 0.0%
FOLD AMICUS THERAPEUTICS INC 2.4%
Value $8.472M Shares 600,000 Est. Cost $14.57 Unrealized 0.0%
AUPH AURINIA PHARMACEUTICALS INC 2.3%
Value $8.102M Shares 550,000 Est. Cost $11.07 Unrealized +30.9%
FATE FATE THERAPEUTICS INC 2.3%
Value $7.994M Shares 200,000 Est. Cost $25.07 Unrealized +39.3%
SURFACE ONCOLOGY INC 2.0%
Value $6.9M Shares 1,000,000 Est. Cost $6.66 Unrealized
KURA KURA ONCOLOGY INC 2.0%
Value $6.894M Shares 225,000 Est. Cost $22.08 Unrealized 0.0%
BCRX BIOCRYST PHARMACEUTICALS INC 1.9%
Value $6.698M Shares 1,950,000 Est. Cost $4.33 Unrealized -1.1%
SNDX SYNDAX PHARMACEUTICALS INC 1.8%
Value $6.273M Shares 425,000 Est. Cost $12.69 Unrealized +20.1%
AGIO AGIOS PHARMACEUTICALS INC 1.8%
Value $6.125M Shares 175,000 Est. Cost $45.46 Unrealized -3.6%
IVERIC BIO INC 1.6%
Value $5.64M Shares 1,000,000 Est. Cost $7.63 Unrealized
TGTX TG THERAPEUTICS INC 1.5%
Value $5.352M Shares 200,000 Est. Cost $14.42 Unrealized +59.6%
VERONA PHARMA PLC 1.5%
Value $5.027M Shares 805,556 Est. Cost $6.24 Unrealized
IMUX IMMUNIC INC 1.4%
Value $4.921M Shares 265,000 Est. Cost $16.38 Unrealized 0.0%
ARVN ARVINAS INC 1.4%
Value $4.722M Shares 200,000 Est. Cost $27.91 Unrealized +3.8%
KALV KALVISTA PHARMACEUTICALS INC 1.3%
Value $4.407M Shares 350,000 Est. Cost $15.74 Unrealized -20.6%
AVADEL PHARMACEUTICALS PLC 1.2%
Value $4.158M Shares 825,000 Est. Cost $8.02 Unrealized
RAPT THERAPEUTICS INC 1.1%
Value $3.703M Shares 115,000 Est. Cost $32.20 Unrealized
WVE WAVE LIFE SCIENCES LTD 1.0%
Value $3.608M Shares 425,000 Est. Cost $9.41 Unrealized +16.5%
XENE XENON PHARMACEUTICALS INC 1.0%
Value $3.598M Shares 325,000 Est. Cost $14.24 Unrealized -17.4%
NEXTCURE INC 1.0%
Value $3.52M Shares 400,000 Est. Cost $8.80 Unrealized
MYOVANT SCIENCES LTD 1.0%
Value $3.513M Shares 250,000 Est. Cost $13.68 Unrealized
REATA PHARMACEUTICALS INC 0.8%
Value $2.923M Shares 30,000 Est. Cost $121.68 Unrealized
ALT ALTIMMUNE INC 0.8%
Value $2.64M Shares 200,000 Est. Cost $9.12 Unrealized +119.2%
RGNX REGENXBIO INC 0.6%
Value $2.064M Shares 75,000 Est. Cost $32.60 Unrealized 0.0%
MILLENDO THERAPEUTICS INC 0.4%
Value $1.508M Shares 925,000 Est. Cost $1.63 Unrealized
HOMOLOGY MEDICINES INC 0.4%
Value $1.445M Shares 135,000 Est. Cost $15.49 Unrealized
IMV INC 0.4%
Value $1.443M Shares 325,000 Est. Cost $4.44 Unrealized
BIIB BIOGEN INC 0.3%
Value $1.191M Shares 4,200 Est. Cost $278.91 Unrealized 0.0%
GRAYBUG VISION INC 0.3%
Value $953K Shares 75,000 Est. Cost $12.71 Unrealized
SATSUMA PHARMACEUTICALS INC 0.2%
Value $778K Shares 200,000 Est. Cost $26.31 Unrealized
MRNA MODERNA INC 0.2%
Value $708K Shares 10,000 Est. Cost $54.76 Unrealized +27.3%
AKBA AKEBIA THERAPEUTICS INC 0.2%
Value $628K Shares 250,000 Est. Cost $8.78 Unrealized 0.0%
AMARIN CORP PLC 0.1%
Value $421K Shares 100,000 Est. Cost $4.21 Unrealized
BRISTOL-MYERS SQUIBB CO 0.1%
Value $281K Shares 125,000 Est. Cost $2.25 Unrealized
CHEMOCENTRYX INC 0.1%
Value $247K Shares 4,500 Est. Cost $54.89 Unrealized